Showing 801 - 820 results of 101,477 for search '(( 5 fold decrease ) OR ( 5 ((((we decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 1.57s Refine Results
  1. 801

    Decrease in IL-4 measured by standard ELISA. by Albert S. Jun (231619)

    Published 2011
    “…Each ELISA value is an average of two measurements. The decrease in IL-4 in the keratoconus pool (7.6±5 pg/ml), compared to controls (14.2±8.6 pg/ml) was statistically significant (p≤0.05, Mann-Whitney test). …”
  2. 802

    Image_5_Consecutive Hypoxia Decreases Expression of NOTCH3, HEY1, CC10, and FOXJ1 via NKX2-1 Downregulation and Intermittent Hypoxia-Reoxygenation Increases Expression of BMP4, NOTCH1, MKI67, OCT4, and MUC5AC via HIF1A Upregulation in Human Bronchial Epithelial Cells.TIF by Yung-Yu Yang (9343376)

    Published 2020
    “…Inhibition of HIF1A or NKX2-1 expression by siRNA transfection respectively decreased BMP4/NOTCH1/MKI67/OCT4/MUC5AC and NOTCH3/HEY1/CC10/FOXJ1 expression in the HBE cells cultured under intermittent H/R to the same levels under normoxia. …”
  3. 803
  4. 804
  5. 805
  6. 806
  7. 807
  8. 808

    Decrease of 4 Asp isomers at 70°C. by Kenzo Aki (386666)

    Published 2013
    “…<p><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0058515#pone-0058515-g007" target="_blank">Figure 7a:</a> decrease of L-α-Asp with incubation of T6-Lα peptide at 70°C. …”
  9. 809
  10. 810
  11. 811
  12. 812
  13. 813
  14. 814
  15. 815
  16. 816

    Decreased TNIP1 expression in SSc patients. by Yannick Allanore (58641)

    Published 2011
    “…(B) Consistent with these findings, a 1.7-fold decrease of <i>TNIP1</i> mRNA levels was observed in dermal fibroblasts from SSc patients (* indicates a <i>P</i>-value = 0.001 <i>vs.…”
  17. 817
  18. 818
  19. 819
  20. 820

    B2 decreases glycolytic intermediates in cells. by Craig Eyster (392633)

    Published 2025
    “…<b>(C)</b> Heatmap of targeted metabolomic data. Each column is a separate biological replicate (n = 5). The box indicates the clustering of decreased downstream glycolytic intermediates in B2-treated cells. …”